Debanjana Chatterjee's Stock Ratings

Jones Trading Analyst

Debanjana Chatterjee is an analyst at Jones Trading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025

Updated: Dec 16, 2025

Overall Average Return

22.0%

Smart Score

71.6%

Overall Average Return Percentile

79th

Number of Ratings

13
Buy NowGet Alert
12/01/2025SYREBuy Now
Spyre Therapeutics
$32.9794.12% → $64UpgradeHold → BuyGet Alert
11/11/2025NTLABuy Now
Intellia Therapeutics
$9.17DowngradeBuy → HoldGet Alert
09/08/2025SIONBuy Now
Sionna Therapeutics
$42.897.25% → $46Initiates → BuyGet Alert
06/17/2025TBPHBuy Now
Theravance Biopharma
$17.5336.91% → $24Initiates → BuyGet Alert
06/06/2025SGMTBuy Now
Sagimet Biosciences
$6.23333.39%$15 → $27MaintainsBuyGet Alert
04/28/2025TVRDBuy Now
Tvardi Therapeutics
$4.26815.49% → $39Initiates → BuyGet Alert
03/26/2025KALVBuy Now
KalVista Pharma
$15.9088.68%$30 → $30MaintainsBuyGet Alert
03/13/2025CTNMBuy Now
Contineum Therapeutics
$11.5599.13% → $23Initiates → BuyGet Alert
01/27/2025SGMTBuy Now
Sagimet Biosciences
$6.23574.16% → $42Initiates → BuyGet Alert
12/11/2024SYREBuy Now
Spyre Therapeutics
$32.97Initiates → HoldGet Alert
09/27/2024KALVBuy Now
KalVista Pharma
$15.90120.13% → $35Initiates → BuyGet Alert
09/19/2024PHVSBuy Now
Pharvaris
$24.4588.14% → $46Initiates → BuyGet Alert
09/17/2024NTLABuy Now
Intellia Therapeutics
$9.17347.11% → $41Initiates → BuyGet Alert